TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 35229613

Group type: EXPERIMENTAL
Intervention: Rifampicin (1 week dosing)
Number of subjects: 102

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 102

Group type: EXPERIMENTAL
Intervention: PXR agonist dosing in rats (6 days)
Number of subjects: 102

Group type: COMPARATOR
Intervention: PXR agonist (withdrawn)
Number of subjects: 102

Group type: EXPERIMENTAL
Intervention: 4βHC
Number of subjects: 102
Study: 35219144

Group type: EXPERIMENTAL
Intervention: Harm and sexual obsession induction paradigms
Number of subjects: 55

Group type: EXPERIMENTAL
Intervention: Shame responses
Number of subjects: 55
Study: 33773170

Group type: EXPERIMENTAL
Intervention: Chemotherapy plus Chinese medicine
Number of subjects: 0

Group type: COMPARATOR
Intervention: Chemotherapy alone
Number of subjects: 0
Study: 34345805

Group type: EXPERIMENTAL
Intervention: Smart About Meds (SAM) mobile application
Number of subjects: 49

Group type: COMPARATOR
Intervention: Usual care (control)
Number of subjects: 49
Study: 33393835

Group type: EXPERIMENTAL
Intervention: Galcanezumab 120 mg
Number of subjects: 411

Group type: EXPERIMENTAL
Intervention: Galcanezumab 240 mg
Number of subjects: 411

Group type: EXPERIMENTAL
Intervention: Galcanezumab 120 mg (EM from placebo-controlled trial)
Number of subjects: 411

Group type: EXPERIMENTAL
Intervention: Galcanezumab 240 mg (EM from placebo-controlled trial)
Number of subjects: 411

Group type: EXPERIMENTAL
Intervention: Galcanezumab 120 mg (CM)
Number of subjects: 411

Group type: EXPERIMENTAL
Intervention: Galcanezumab 240 mg (CM)
Number of subjects: 411

Group type: COMPARATOR
Intervention: Placebo (previously in double-blind trial)
Number of subjects: 411
Study: 35262315

Group type: EXPERIMENTAL
Intervention: Social learning group (SoLG) observing positive treatment outcomes in a sham patient
Number of subjects: 44

Group type: COMPARATOR
Intervention: Control group hearing neutral effects from the sham patient
Number of subjects: 44
Study: 33302884

Group type: EXPERIMENTAL
Intervention: Nurse-led telephone management (NLTM)
Number of subjects: 1154

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 1154
Study: 34051076

Group type: EXPERIMENTAL
Intervention: Lactobacillus buchneri 40788 and Pediococcus pentocaseus 12455 (LBPP)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Sodium benzoate, potassium sorbate, and sodium nitrite (SFE)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Lactobacillus plantarum MTD1 (LP)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Untreated (CTRL)
Number of subjects: 0
Study: 32101336

Group type: EXPERIMENTAL
Intervention: Woman-picked Peak Day
Number of subjects: 57

Group type: EXPERIMENTAL
Intervention: Expert-picked Peak Day
Number of subjects: 57

Group type: EXPERIMENTAL
Intervention: Computer-picked Peak Day
Number of subjects: 57
Study: 34779154

Group type: EXPERIMENTAL
Intervention: Partial Nephrectomy (PN)
Number of subjects: 3196

Group type: COMPARATOR
Intervention: Radical Nephrectomy (RN)
Number of subjects: 3196
Study: 32041664

Group type: EXPERIMENTAL
Intervention: Adolescent-friendly services (AFS) utilization
Number of subjects: 362

Group type: EXPERIMENTAL
Intervention: Factors positively associated with AFS utilization
Number of subjects: 362

Group type: EXPERIMENTAL
Intervention: Qualitative factors affecting AFS utilization
Number of subjects: 362
Study: 35913836

Group type: EXPERIMENTAL
Intervention: Remdesivir
Number of subjects: 82

Group type: EXPERIMENTAL
Intervention: Sotrovimab
Number of subjects: 82

Group type: COMPARATOR
Intervention: Control
Number of subjects: 82
Study: 34081233

Group type: EXPERIMENTAL
Intervention: ICSI at 36.5 h post HCG and/or Lupron trigger
Number of subjects: 12

Group type: COMPARATOR
Intervention: ICSI at 39 h post HCG and/or Lupron trigger
Number of subjects: 12
Study: 32061002

Group type: EXPERIMENTAL
Intervention: Low radiation dose contrast‐enhanced mammography (L‐CEM)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Contrast-enhanced MRI (CE‐MRI)
Number of subjects: 80
Study: 36348309

Group type: EXPERIMENTAL
Intervention: Graded activity receiving cognitive-behavioral therapy (GA)
Number of subjects: 180

Group type: EXPERIMENTAL
Intervention: Supervised group-based combined exercise therapy and education (SET)
Number of subjects: 180

Group type: COMPARATOR
Intervention: Graded activity (GA)
Number of subjects: 180

Group type: COMPARATOR
Intervention: Supervised exercise therapy (SET)
Number of subjects: 180
Study: 33315489

Group type: EXPERIMENTAL
Intervention: Crushed prasugrel tablets (60 mg loading dose)
Number of subjects: 727

Group type: COMPARATOR
Intervention: Integral prasugrel tablets (60 mg loading dose)
Number of subjects: 727
Study: 36054089

Group type: EXPERIMENTAL
Intervention: Melatonin (5 mg daily)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study: 33142248

Group type: EXPERIMENTAL
Intervention: Web-based data visualization tool for reviewing de-identified anesthesia records
Number of subjects: 19

Group type: COMPARATOR
Intervention: Baseline assessment
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: Subsequent assessments with the tool
Number of subjects: 19
Study: 32399130

Group type: EXPERIMENTAL
Intervention: Acupuncture at Zhongwan (CV 12) and Zusanli (ST 36)
Number of subjects: 99

Group type: EXPERIMENTAL
Intervention: Acupuncture at Neiguan (PC 6) and Zusanli (ST 36)
Number of subjects: 99

Group type: COMPARATOR
Intervention: Acupuncture at nonacupoint and Zusanli (ST 36)
Number of subjects: 99

Group type: EXPERIMENTAL
Intervention: All groups (A, B, C)
Number of subjects: 99
Study: 35697297

Group type: EXPERIMENTAL
Intervention: Hands-off technique
Number of subjects: 70

Group type: COMPARATOR
Intervention: Hands-on technique (Control)
Number of subjects: 70
Study: 32770222

Group type: EXPERIMENTAL
Intervention: Graphic warning labels with 'US Food and Drug Administration' sponsorship
Number of subjects: 487

Group type: EXPERIMENTAL
Intervention: Graphic warning labels with 'American Cancer Society' sponsorship
Number of subjects: 487

Group type: COMPARATOR
Intervention: Graphic warning labels with no sponsor
Number of subjects: 487
Study: 35695680

Group type: EXPERIMENTAL
Intervention: Responsive language facilitation strategies
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Directive language facilitation strategies
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Parent-mediated intervention
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Teaching mothers to use responsive strategies
Number of subjects: 0
Study: 34197268

Group type: EXPERIMENTAL
Intervention: Psychotropic medications
Number of subjects: 175

Group type: EXPERIMENTAL
Intervention: Psychotropic medications in ATC groups N05/N06A
Number of subjects: 175

Group type: EXPERIMENTAL
Intervention: Beers Criteria
Number of subjects: 175
Study: 32871662

Group type: EXPERIMENTAL
Intervention: Individualized Training (IT)
Number of subjects: 62

Group type: EXPERIMENTAL
Intervention: Generalized Training (GT)
Number of subjects: 62

Group type: COMPARATOR
Intervention: Control Group (CG)
Number of subjects: 62
Study: 36200450

Group type: EXPERIMENTAL
Intervention: High-Intensity Interval Training (HIIT)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Moderate Continuous Exercise Training
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (guideline based advice for ET)
Number of subjects: 0
Study: 33210285

Group type: EXPERIMENTAL
Intervention: Vasopressin (20 units)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Control (20 cc normal saline)
Number of subjects: 60
Study: 33198235

Group type: EXPERIMENTAL
Intervention: Plant-rich diets containing fresh fruits, nuts, seeds, and peanuts
Number of subjects: 226

Group type: EXPERIMENTAL
Intervention: Animal product-rich diets
Number of subjects: 226

Group type: COMPARATOR
Intervention: Cognition
Number of subjects: 226
Study: 34954933

Group type: EXPERIMENTAL
Intervention: BM-PIOMI
Number of subjects: 68
Study: 33121714

Group type: EXPERIMENTAL
Intervention: Canagliflozin
Number of subjects: 4330

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 4330

Group type: EXPERIMENTAL
Intervention: Baseline NT-proBNP ≥125 pg/ml
Number of subjects: 4330
Study: 35745239

Group type: EXPERIMENTAL
Intervention: Dewaxed Coffee (DC)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Standard Coffee (SC)
Number of subjects: 40
Study: 34051733

Group type: EXPERIMENTAL
Intervention: Nomogram and risk classification system for predicting overall survival (OS) in SCLC patients with brain metastasis
Number of subjects: 3522

Group type: EXPERIMENTAL
Intervention: Nomogram and risk classification system
Number of subjects: 3522

Group type: EXPERIMENTAL
Intervention: Nomogram
Number of subjects: 3522

Group type: COMPARATOR
Intervention: Cox regression analysis
Number of subjects: 3522
Study: 35477641

Group type: EXPERIMENTAL
Intervention: HP-3070 7.6 mg/24 h
Number of subjects: 369

Group type: EXPERIMENTAL
Intervention: HP-3070 3.8 mg/24 h
Number of subjects: 369

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 369
Study: 33367669

Group type: EXPERIMENTAL
Intervention: Radiofrequency catheter ablation (RFCA)
Number of subjects: 648
Study: 35994019

Group type: EXPERIMENTAL
Intervention: Prewarming with forced-air warming (FAW) device
Number of subjects: 104
Study: 32281404

Group type: EXPERIMENTAL
Intervention: Intracavitary tissue plasminogen activator (tPA)
Number of subjects: 28

Group type: COMPARATOR
Intervention: Saline treatment
Number of subjects: 28
Study: 32717033

Group type: EXPERIMENTAL
Intervention: Brain-responsive neurostimulation of the nucleus accumbens using the RNS® System (NeuroPace Inc) for LOC eating.
Number of subjects: 6
Study: 33412344

Group type: EXPERIMENTAL
Intervention: Nonnutritive sucking (NNS) twice a day for 10 days during two consecutive weeks
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Combined program of NNS (15 min) and swallowing exercise (SE) (15 min) daily for 10 days during two consecutive weeks
Number of subjects: 45

Group type: COMPARATOR
Intervention: Routine NICU care
Number of subjects: 45
Study: 33848307

Group type: EXPERIMENTAL
Intervention: Pure essential oil therapy (sandalwood)
Number of subjects: 43

Group type: EXPERIMENTAL
Intervention: Blended essential oil therapy (sandalwood-lavender)
Number of subjects: 43

Group type: COMPARATOR
Intervention: Control (no essential oil)
Number of subjects: 43
Study: 33362439

Group type: EXPERIMENTAL
Intervention: Diaphragm Release Technique (DRT)
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Rib Mobilization Technique + Diaphragm Release Technique (RMT+DRT)
Number of subjects: 14
Study: 34661770

Group type: EXPERIMENTAL
Intervention: Buccal pad of fat sandwiched with a nasolabial flap (Group I)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Buccal pad of fat combined with a collagen graft (Group II)
Number of subjects: 40
Study: 34876412

Group type: EXPERIMENTAL
Intervention: Guide to Action for Care Homes (GtACH) multifactorial fall prevention programme
Number of subjects: 1657

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 1657

Group type: EXPERIMENTAL
Intervention: Guide to Action for Care Homes (GtACH)
Number of subjects: 1657
Study: 33065181

Group type: EXPERIMENTAL
Intervention: MRI-based IGBT with ureteral dose D0.1cm3 ≥77 Gy
Number of subjects: 242

Group type: COMPARATOR
Intervention: MRI-based IGBT with ureteral dose D0.1cm3 <77 Gy
Number of subjects: 242

Group type: EXPERIMENTAL
Intervention: MRI-based IGBT with ureteral dose D0.1cm3 ≥85 Gy
Number of subjects: 242

Group type: EXPERIMENTAL
Intervention: MRI-based IGBT with ureteral dose D0.1cm3 ≥90 Gy
Number of subjects: 242

Group type: EXPERIMENTAL
Intervention: MRI-based IGBT without pre-existing hydronephrosis
Number of subjects: 242

Group type: EXPERIMENTAL
Intervention: MRI-based IGBT with late grade ≥3 US
Number of subjects: 242
Study: 34013470

Group type: EXPERIMENTAL
Intervention: SHE (brief motivational interviewing and psychoeducation‐based computerized intervention)
Number of subjects: 153

Group type: COMPARATOR
Intervention: Control group (screen and referral‐only condition)
Number of subjects: 153
Study: 34498740

Group type: EXPERIMENTAL
Intervention: High-throughput sequence-based method for predicting extant fold switchers; method leverages JPred4 predictions of ?-helix to ?-strand discrepancies.
Number of subjects: 99

Group type: EXPERIMENTAL
Intervention: Classifier developed from predicted discrepancies and overall percentage of predicted secondary structure.
Number of subjects: 99
Study: 32219775

Group type: EXPERIMENTAL
Intervention: Salvage lymph node dissection (SLND)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: PSMA PET/CT imaging
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: PSMA radioguided surgery
Number of subjects: 0
Study: 33028559

Group type: EXPERIMENTAL
Intervention: Hydrocolloid dressing with moisturising care
Number of subjects: 26

Group type: COMPARATOR
Intervention: Standard supportive care (moisturising care alone)
Number of subjects: 26
Study: 615919275

Group type: EXPERIMENTAL
Intervention: 0.3 mg RBZ
Number of subjects: 759

Group type: EXPERIMENTAL
Intervention: 0.5 mg RBZ
Number of subjects: 759

Group type: COMPARATOR
Intervention: Sham/crossover
Number of subjects: 759
Study: 35484175

Group type: EXPERIMENTAL
Intervention: Thiamine
Number of subjects: 115

Group type: EXPERIMENTAL
Intervention: Thiamine plus MgSO4
Number of subjects: 115

Group type: EXPERIMENTAL
Intervention: MgSO4
Number of subjects: 115

Group type: COMPARATOR
Intervention: All groups
Number of subjects: 115
Study: 34869434

Group type: EXPERIMENTAL
Intervention: Cricothyroid membrane puncture anesthesia
Number of subjects: 70

Group type: COMPARATOR
Intervention: Topical anesthesia
Number of subjects: 70
Study: 35587540

Group type: EXPERIMENTAL
Intervention: Vaginal misoprostol 25 μg followed by 50 μg every 4 hours
Number of subjects: 47

Group type: COMPARATOR
Intervention: Buccal misoprostol 25 μg followed by 50 μg every 4 hours
Number of subjects: 47
Study: 32649584

Group type: EXPERIMENTAL
Intervention: Interactive educational workshop with standardized patients (SPs)
Number of subjects: 62

Group type: COMPARATOR
Intervention: Interactive educational workshop without standardized patients (SPs)
Number of subjects: 62
Study: 35278780

Group type: EXPERIMENTAL
Intervention: Internet-based cognitive-behavioral grief therapy (ICBGT)
Number of subjects: 57
Study: 34621545

Group type: EXPERIMENTAL
Intervention: Polyethylene cover
Number of subjects: 156

Group type: EXPERIMENTAL
Intervention: Polyethylene cover plus artificial tear drops
Number of subjects: 156

Group type: EXPERIMENTAL
Intervention: Polyethylene cover plus Lubratex eye ointment
Number of subjects: 156

Group type: COMPARATOR
Intervention: Routine interventions (control eye)
Number of subjects: 156
Study: 34392146

Group type: EXPERIMENTAL
Intervention: 80 mg/day anthocyanins for 12 weeks
Number of subjects: 93

Group type: EXPERIMENTAL
Intervention: 320 mg/day anthocyanins for 12 weeks
Number of subjects: 93

Group type: EXPERIMENTAL
Intervention: Dose-response relationship of anthocyanins
Number of subjects: 93

Group type: EXPERIMENTAL
Intervention: Changes in platelet aggregation
Number of subjects: 93

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 93
Study: 33291311

Group type: EXPERIMENTAL
Intervention: Vibrating roller
Number of subjects: 23

Group type: COMPARATOR
Intervention: Foam roller
Number of subjects: 23
Study: 36224664

Group type: EXPERIMENTAL
Intervention: internet-based counselling with a cognitive-behavioural approach
Number of subjects: 92
Study: 33899649

Group type: COMPARATOR
Intervention: MET 1000 mg alone
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: FOT 24 mg and MET
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: FOT 24 mg alone
Number of subjects: 18
Study: 616542999

Group type: EXPERIMENTAL
Intervention: Student question creation exercise
Number of subjects: 84

Group type: COMPARATOR
Intervention: Traditional case‐based application exercise
Number of subjects: 84
Study: 35158205

Group type: EXPERIMENTAL
Intervention: Durvalumab (20 mg/kg/i.v. every 4 weeks for 12 months)
Number of subjects: 86

Group type: EXPERIMENTAL
Intervention: Durvalumab (in PD-L1-positive group)
Number of subjects: 86

Group type: COMPARATOR
Intervention: Placebo (in PD-L1-positive group)
Number of subjects: 86

Group type: EXPERIMENTAL
Intervention: Durvalumab (in PD-L1-negative group)
Number of subjects: 86

Group type: COMPARATOR
Intervention: Placebo (in PD-L1-negative group)
Number of subjects: 86
Study: 33693703

Group type: EXPERIMENTAL
Intervention: Transdermal 17-beta estradiol 0.1 mg/day with 30 mcg/kg/dose of rhIGF-1 administered subcutaneously twice daily (AN-IGF-1+)
Number of subjects: 75

Group type: COMPARATOR
Intervention: Transdermal 17-beta estradiol 0.1 mg/day with placebo (AN-IGF-1-)
Number of subjects: 75
Study: 32639592

Group type: EXPERIMENTAL
Intervention: Mindfulness-based intervention (MBI)
Number of subjects: 33

Group type: COMPARATOR
Intervention: Waitlist control condition
Number of subjects: 33
Study: 36188367

Group type: EXPERIMENTAL
Intervention: Tasimelteon
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 33487271

Group type: EXPERIMENTAL
Intervention: Probiotic (500 mg)
Number of subjects: 88

Group type: EXPERIMENTAL
Intervention: Alpha-lipoic acid (ALA) (600 mg) and probiotic
Number of subjects: 88

Group type: EXPERIMENTAL
Intervention: Alpha-lipoic acid (ALA)
Number of subjects: 88

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 88
Study: 34554264

Group type: EXPERIMENTAL
Intervention: Attention Process Training (APT)
Number of subjects: 51

Group type: COMPARATOR
Intervention: Activity‐based Attention Training (ABAT)
Number of subjects: 51
Study: 34189933

Group type: EXPERIMENTAL
Intervention: PeerFIT group lifestyle intervention
Number of subjects: 150

Group type: COMPARATOR
Intervention: BEAT one‐on‐one mHealth coaching
Number of subjects: 150
Study: 34258785

Group type: EXPERIMENTAL
Intervention: k-resolution sequential randomization (k-RSR) procedure
Number of subjects: 0

Group type: COMPARATOR
Intervention: pairwise sequential randomization (PSR) procedure
Number of subjects: 0
Study: 32187404

Group type: EXPERIMENTAL
Intervention: Painful cold
Number of subjects: 38

Group type: EXPERIMENTAL
Intervention: Painful, unpleasant and pleasant mechanical stimuli
Number of subjects: 38

Group type: EXPERIMENTAL
Intervention: Pleasant mechanical stimulus
Number of subjects: 38

Group type: EXPERIMENTAL
Intervention: Thermal or mechanical stimuli
Number of subjects: 38

Group type: COMPARATOR
Intervention: Control stimuli
Number of subjects: 38
Study: 35246206

Group type: EXPERIMENTAL
Intervention: Swine dermal collagen prosthesis implanted preperitoneally as a prophylactic procedure
Number of subjects: 90

Group type: COMPARATOR
Intervention: Normal wall abdominal closure
Number of subjects: 90
Study: 34006077

Group type: EXPERIMENTAL
Intervention: Photofunctionalised implant
Number of subjects: 34

Group type: COMPARATOR
Intervention: Untreated implant (control group)
Number of subjects: 34
Study: 33905790

Group type: EXPERIMENTAL
Intervention: Decentering
Number of subjects: 108

Group type: EXPERIMENTAL
Intervention: Visualisation
Number of subjects: 108

Group type: COMPARATOR
Intervention: Mind-wandering control
Number of subjects: 108
Study: 32008434

Group type: EXPERIMENTAL
Intervention: Urine sodium-potassium ratio (UNa/UK)
Number of subjects: 478311

Group type: EXPERIMENTAL
Intervention: Urine albumin adjusted for creatinine
Number of subjects: 478311

Group type: EXPERIMENTAL
Intervention: UNa/UK and urine albumin adjusted for creatinine
Number of subjects: 478311
Study: 35817759

Group type: EXPERIMENTAL
Intervention: Youth with anxiety
Number of subjects: 105

Group type: COMPARATOR
Intervention: No psychiatric diagnosis (ND)
Number of subjects: 105

Group type: EXPERIMENTAL
Intervention: Parent-reported sleep problems
Number of subjects: 105
Study: 34617916

Group type: EXPERIMENTAL
Intervention: PedAMINES mobile app
Number of subjects: 150

Group type: COMPARATOR
Intervention: Conventional preparation methods
Number of subjects: 150
Study: 32156838

Group type: COMPARATOR
Intervention: Isotonic saline (Group A)
Number of subjects: 201

Group type: COMPARATOR
Intervention: Isotonic saline plus N‐acetylcysteine (1200mg twice a day for 2 days) (Group B)
Number of subjects: 201

Group type: COMPARATOR
Intervention: Isotonic saline plus daily alpha tocopherol (600 IU once daily from one day before till 2 days after angiography for 4 days) (Group C)
Number of subjects: 201
Study: 35429246

Group type: EXPERIMENTAL
Intervention: CHP‐NY‐ESO‐1 vaccination
Number of subjects: 54

Group type: COMPARATOR
Intervention: Observation (Control)
Number of subjects: 54
Study: 34090982

Group type: EXPERIMENTAL
Intervention: Observational studies designed to mimic RCTs
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Target trial framework
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Design elements of RCTs
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Example target trial emulating TRITON-TIMI-38
Number of subjects: 0
Study: 33217362

Group type: EXPERIMENTAL
Intervention: Low-dose CoronaVac (3 μg per 0.5 mL)
Number of subjects: 743

Group type: EXPERIMENTAL
Intervention: High-dose CoronaVac (6 μg per 0.5 mL)
Number of subjects: 743

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 743
Study: 37232538

Group type: EXPERIMENTAL
Intervention: Urotherapy and parasacral TENS (20 sessions, 3 times weekly, 20 min each, 10 Hz frequency, 700 μS pulse width)
Number of subjects: 72

Group type: COMPARATOR
Intervention: Urotherapy (control group)
Number of subjects: 72
Study: 33563987

Group type: EXPERIMENTAL
Intervention: Participation in optional components
Number of subjects: 451306

Group type: EXPERIMENTAL
Intervention: Longer educational duration, older menarche, taller stature
Number of subjects: 451306

Group type: EXPERIMENTAL
Intervention: Higher levels of adiposity, dyslipidaemia, neuroticism, Alzheimer’s, schizophrenia
Number of subjects: 451306
Study: 33136172

Group type: EXPERIMENTAL
Intervention: 1-day ART
Number of subjects: 79

Group type: EXPERIMENTAL
Intervention: 3-day ART
Number of subjects: 79

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 79
Study: 34260454

Group type: EXPERIMENTAL
Intervention: 2.5 IU Botulinum Toxin (BT) injection at 1 point per side (2‐points group)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: 5 IU Botulinum Toxin (BT) injection at 2 points per side (4‐points group)
Number of subjects: 40
Study: 33797076

Group type: EXPERIMENTAL
Intervention: CBD10 (10 mg/kg/day)
Number of subjects: 396

Group type: EXPERIMENTAL
Intervention: CBD20 (20 mg/kg/day)
Number of subjects: 396

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 396

Group type: EXPERIMENTAL
Intervention: CBD (both doses)
Number of subjects: 396
Study: 35272303

Group type: EXPERIMENTAL
Intervention: FASD (force-activated separation device)
Number of subjects: 302

Group type: COMPARATOR
Intervention: SOC (standard of care)
Number of subjects: 302

Group type: EXPERIMENTAL
Intervention: FASD
Number of subjects: 302

Group type: COMPARATOR
Intervention: SOC
Number of subjects: 302
Study: 32814667

Group type: EXPERIMENTAL
Intervention: Step-up oral food challenge testing (SOFT)
Number of subjects: 55

Group type: COMPARATOR
Intervention: Home incrementing group
Number of subjects: 55

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 55